Stay updated on Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to a feasibility study of sequential hepatic internal radiation and systemic ipilimumab and nivolumab in patients with uveal melanoma metastatic to the liver.
    Difference
    0.1%
    Check dated 2024-06-06T14:25:15.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change includes examples of criteria such as a person's general health condition or prior treatments.
    Difference
    38%
    Check dated 2024-05-22T21:11:29.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:35:55.000Z thumbnail image

Stay in the know with updates to Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.